Chapter 3 46 Tables Table 1. Baseline characteristics Characteristic Uninterrupted VKA N=520 Interrupted NOAC N=117 P-value Age (years), mean ± SD 60 ± 10 60 ± 9 0.55 Male sex, n (%) 354 (68) 84 (72) 0.43 Atrial fibrillation, n (%): 0.048 Paroxysmal 392 (76) 86 (74) Persistent 116 (22) 24 (20) Long-standing persistent 10 (2) 7 (6) Hypertension 217 (42) 44 (38) 0.41 Diabetes mellitus 52 (10) 5 (4) 0.05 Coronary artery disease 62 (12) 7 (6) 0.06 Congestive heart failure 20 (4) 2 (2) 0.25 Left ventricular dysfunction 18 (3) 5 (4) 0.58 LA diameter (mm), mean ± SD 42 ± 6 43 ± 7 0.56 CHA2DS2-VASc score ≥ 2, n (%) 245 (47) 40 (34) 0.02 HAS-BLED score ≥ 3, n (%) 31 (6) 4 (3) 0.30 Body mass index, mean ± SD (kg/m2) 27.7 ± 4.1 27.2 ± 3.3 0.23 Technique of catheter ablation, n (%): 0.09 Cryoballoon 100 (19) 33 (28) Radiofrequency 402 (78) 83 (71) Laser 18 (3) 1 (1) LA = left atrium, NOAC = novel oral anticoagulant, VKA = vitamin K antagonist
RkJQdWJsaXNoZXIy MTk4NDMw